Loading...

Myriad Genetics, Inc.

0K3W.LLSE
Healthcare
Medical - Pharmaceuticals
£4.53
£-0.04(-0.85%)

Myriad Genetics, Inc. 0K3W.L Peers

See (0K3W.L) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
0K3W.L£4.53-0.85%414.7M-41.28-£0.11N/A
0R0H.L£421.98+2.29%154.9B21.39£19.19+0.50%
0QZU.L£466.91+1.70%118.4B48.65£9.48N/A
0M3Q.L£149.46+0.99%65.7B33.88£4.36+1.31%
0R2M.L£559.34+2.97%58.4B7.83£70.31+0.32%
0HD2.L£321.21+0.47%42B-43.04-£7.49N/A
0RD1.L£697.00+0.34%41.9B-557.36-£1.27N/A
0HAV.L£115.00+0.29%32.1B27.25£4.15+0.87%
0JDM.L£187.92+16.90%27.6B28.83£5.54N/A
0K10.L£1,206.32+0.52%24.7B34.95£34.05N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

0K3W.L vs 0R0H.L Comparison

0K3W.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0K3W.L stands at 414.7M. In comparison, 0R0H.L has a market cap of 154.9B. Regarding current trading prices, 0K3W.L is priced at £4.53, while 0R0H.L trades at £421.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0K3W.L currently has a P/E ratio of -41.28, whereas 0R0H.L's P/E ratio is 21.39. In terms of profitability, 0K3W.L's ROE is -0.14%, compared to 0R0H.L's ROE of +0.13%. Regarding short-term risk, 0K3W.L is less volatile compared to 0R0H.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K3W.L.

Stock Price Comparison

Loading...

Frequently Asked Questions

;